| Identification | Back Directory | [Name]
3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxaMide | [CAS]
356782-84-8 | [Synonyms]
T 1106
β-Anomer
β-Anomer, 10 mM in DMSO
3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxaMide
4-β-D-ribofuranosyl-3,4-dihydro-3-oxo-2-pyrazine carboxamide
3-Oxo-4-(?-D-Ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-
3,4-dihydro-3-oxo-4-beta-D-ribofuranosyl-2-pyrazinecarboxamide
4-beta-D-ribofuranosyl-3,4-dihydro-3-oxo-2-pyrazine carboxamide
4-beta-D-ribofuranosyl-3,4-dihydro-3-oxo-2-pyrazine carboxamide, T-1106
4-β-D-ribofuranosyl-3,4-dihydro-3-oxo-2-pyrazine carboxamide, T-1106, antiviral agent, Phlebovirus | [Molecular Formula]
C10H13N3O6 | [MDL Number]
MFCD31707482 | [MOL File]
356782-84-8.mol | [Molecular Weight]
271.23 |
| Hazard Information | Back Directory | [Uses]
3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
| Company Name: |
Carbosynth
|
| Tel: |
+86 512 6260 5585 |
| Website: |
www.carbosynth.com |
|